T2 Biosystems Inc (TTOO)
5.15
+0.09
(+1.78%)
USD |
NASDAQ |
May 31, 16:00
5.20
+0.05
(+0.97%)
Pre-Market: 20:00
T2 Biosystems Enterprise Value: 123.35M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 123.35M |
| May 30, 2024 | 121.81M |
| May 29, 2024 | 122.32M |
| May 28, 2024 | 121.81M |
| May 24, 2024 | 119.94M |
| May 23, 2024 | 123.52M |
| May 22, 2024 | 131.54M |
| May 21, 2024 | 128.47M |
| May 20, 2024 | 138.88M |
| May 17, 2024 | 131.71M |
| May 16, 2024 | 131.71M |
| May 15, 2024 | 137.34M |
| May 14, 2024 | 106.45M |
| May 13, 2024 | 102.92M |
| May 10, 2024 | 92.24M |
| May 09, 2024 | 84.48M |
| May 08, 2024 | 76.76M |
| May 07, 2024 | 79.33M |
| May 06, 2024 | 84.61M |
| May 03, 2024 | 85.83M |
| May 02, 2024 | 67.55M |
| May 01, 2024 | 61.84M |
| April 30, 2024 | 64.96M |
| April 29, 2024 | 61.31M |
| April 26, 2024 | 60.43M |
| Date | Value |
|---|---|
| April 25, 2024 | 59.55M |
| April 24, 2024 | 59.73M |
| April 23, 2024 | 59.38M |
| April 22, 2024 | 63.24M |
| April 19, 2024 | 61.49M |
| April 18, 2024 | 61.75M |
| April 17, 2024 | 61.31M |
| April 16, 2024 | 62.10M |
| April 15, 2024 | 61.57M |
| April 12, 2024 | 63.07M |
| April 11, 2024 | 52.82M |
| April 10, 2024 | 52.38M |
| April 09, 2024 | 52.71M |
| April 08, 2024 | 51.00M |
| April 05, 2024 | 51.06M |
| April 04, 2024 | 51.22M |
| April 03, 2024 | 50.84M |
| April 02, 2024 | 51.77M |
| April 01, 2024 | 51.88M |
| March 31, 2024 | 51.99M |
| March 28, 2024 | 42.13M |
| March 27, 2024 | 40.64M |
| March 26, 2024 | 39.70M |
| March 25, 2024 | 40.29M |
| March 22, 2024 | 39.75M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
30.93M
Minimum
Nov 30 2023
28.06B
Maximum
Feb 08 2021
4.210B
Average
3.121B
Median
Enterprise Value Benchmarks
| Abeona Therapeutics Inc | 136.13M |
| Nortech Systems Inc | 35.09M |
| INVO Bioscience Inc | 12.27M |
| SINTX Technologies Inc | -1.081M |
| Tactile Systems Technology Inc | 255.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.53M |
| Revenue (Quarterly) | 2.061M |
| Total Expenses (Quarterly) | 14.66M |
| EPS Diluted (Quarterly) | -2.66 |
| Gross Profit Margin (Quarterly) | -103.9% |
| Profit Margin (Quarterly) | -656.7% |
| Earnings Yield | -323.5% |
| Normalized Earnings Yield | -506.28 |